Skip to main content

Table 3 Analysis of factors significantly associated with gain over predicted adult height

From: Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study

Gain Over Baseline Predicted Adult Heighta

Univariate Analysis

Correlation Coefficient

P-value

At the start of therapy

   

CA (yr)

-0.43

0.0221

BA minus CA

0.53

0.004

Time to treatment from onset of CPP (yr)

-0.39

0.0395

During therapy

   

Duration of the treatment

0.52

0.0048

At the end of therapy

   

CA

0.40

0.0369

Multiple Linear Regression

Beta Coefficient

P-value

R 2

BA-CA at baseline

3.37

0.0028

 

Time to Treatment from onset of CPP (yr)

-3.84

0.0245

0.41

  1. aAdult height minus predicted mature height at baseline